Share on StockTwits

Shares of Kimberly-Clark Corp. (NYSE:KMB) have been given an average recommendation of “Hold” by the seventeen analysts that are currently covering the stock, AmericanBankingNews.com reports. Two investment analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $105.55.

Shares of Kimberly-Clark Corp. (NYSE:KMB) traded up 0.29% during mid-day trading on Thursday, hitting $109.03. 564,996 shares of the company’s stock traded hands. Kimberly-Clark Corp. has a 52-week low of $91.44 and a 52-week high of $113.09. The stock has a 50-day moving average of $110.0 and a 200-day moving average of $106.. The company has a market cap of $41.366 billion and a price-to-earnings ratio of 19.66.

Kimberly-Clark Corp. (NYSE:KMB) last announced its earnings results on Monday, April 21st. The company reported $1.48 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.47 by $0.01. The company had revenue of $5.30 billion for the quarter, compared to the consensus estimate of $5.31 billion. During the same quarter in the prior year, the company posted $1.36 earnings per share. The company’s quarterly revenue was down .8% on a year-over-year basis. On average, analysts predict that Kimberly-Clark Corp. will post $6.11 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on KMB shares. Analysts at Zacks reiterated a “neutral” rating on shares of Kimberly-Clark Corp. in a research note on Wednesday. They now have a $114.00 price target on the stock. Finally, analysts at BTIG Research initiated coverage on shares of Kimberly-Clark Corp. in a research note on Wednesday, January 29th. They set a “neutral” rating on the stock.

Kimberly-Clark Corporation (NYSE:KMB) is a global company focused on the world in essentials for a better life through product innovation and building its personal care, consumer tissue, K C professional and health care brands.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.